share_log

公告精选 | 理想汽车Q1营收同比增167.5%至95.6亿元;贝壳-W:A类普通股拟今日于联交所开始买卖

Selected Announcements | Ideal Auto's Q1 revenue increased 167.5% year-on-year to 9.56 billion yuan; Shell-W: Class A common stock plans to start trading on the Stock Exchange today

富途資訊 ·  May 11, 2022 08:45

Selection of blockbuster announcements

1、$Li Auto Inc.-W (02015.HK) $Revenue in the first quarter increased by 167.5% to 9.56 billion yuan compared with the same period last year, and delivery is expected to be 21000-24000 vehicles in the second quarter.

Li Auto Inc. announced that total revenue in the first quarter was 9.56 billion yuan, up 167 percent from 3.58 billion yuan in the first quarter of 2021 and down 10.0 percent from 10.62 billion yuan in the fourth quarter of 2021. The net loss was 10.9 million yuan, compared with a net loss of 360 million yuan in the first quarter of 2021 and a net profit of 295.5 million yuan in the fourth quarter of 2021. Without Non-GAAP, the net profit was 477.1 million yuan, compared with a net loss of 177 million yuan in the first quarter of 2021 and a net profit of 686.4 million yuan in the fourth quarter of 2021.

In the first quarter of 2022, ideal ONE deliveries were 31716, an increase of 152.1 per cent year-on-year. In the second quarter of 2022, the company expects to deliver 21000 to 24000 vehicles, an increase of 19.5% to 36.6% over the second quarter of 2021.

2、$Geely Automobile (00175.HK) $Car sales in April were 72200, down about 28% from the same period last year

Geely sold 72200 cars in April, down about 28% from the same period last year, mainly affected by repeated outbreaks in some areas and persistent shortages in the supply chain. Of these, pure electric vehicles (BEVs) sold about 10900 units in April, up 5.52 times year-on-year, and 50500 units from January to April, up 6.87 times year-on-year.

3、$AAC Technologies Holdings Inc. (02018.HK) $Chengrui Optics introduces new strategic investors

AAC Technologies Holdings Inc. announced that on May 10, 2022, the seller (one of the strategic investors in Chengrui Optics) entered into a share transfer agreement relating to the transfer of a total of 0.5488%, 0.1098%, 0.1646% and 0.7133% of the issued shares of Chengrui Optical to Changzhou Xinbei, Changzhou Changgaoxin, Nanning Canton and AAC Hong Kong respectively. Upon completion, the seller will remain a strategic investor in Chengrui Optical, holding a total of 0.5488% of the issued shares of Chengrui Optics.

4、$Lutheran electricity Storage (08328.HK) $Net profit rose 1766.2% to HK $3.751 million in the first quarter.

Xinyi Storage Power announced that in the first quarter ended March 31, 2022, the company's revenue was HK $106 million, an increase of 145.0% over the same period last year; the profit attributable to the company's owners was HK $3.751 million, an increase of 1766.2% over the same period last year; and basic earnings per share was HK0.53 cents. The significant increase in net profit was mainly due to the increase in sales revenue and gross profit attributable to EPC services for the three months ended March 31, 2022.

5、$KE Holdings Inc.-W (02423.HK) $Class A common shares are scheduled to start trading on the Stock Exchange on May 11

KE Holdings Inc.-W announced that as at the date of this announcement, there are approximately 3.793 billion ordinary shares in issue and outstanding, including approximately 2.908 billion Class An ordinary shares and approximately 885 million Class B ordinary shares (including approximately 727 million Class B ordinary shares held by Propitious Global which will be converted into Class An ordinary shares immediately after the completion of the introduction listing).

6、$Junshi creature (01877.HK) $Notice of approval of supplementary drug application for triplet monoclonal antibody

According to Junshi Biological announcement, the company has received a notice of approval for supplementary drug application issued by the State Drug Administration, approving the production base of Shanghai Junshi Biological Engineering Co., Ltd. ("Junshi Engineering"), a wholly-owned subsidiary of the company, which is located in Lingang, Shanghai, and the company's Wujiang production base in Suzhou is responsible for the production of commercial batches of triplizumab injection (trade name: Tuoyi, product code: JS001).

Listing of new shares

KE Holdings Inc.-W (02423): class An ordinary shares are scheduled to start trading on the Stock Exchange on May 11.

Important matters

Gome Retail (00493): Gome has fully redeemed its domestic bonds in 2016

Jingneng Clean Energy (00579) intends to replace the 84.68% stake in Shenzhen Jingneng Leasing with its 20% stake and cash.

Green Leaf Pharmaceutical (02186): class 1 new drug LY 03014 completes phase I clinical trial in China

Sansheng Pharmaceutical (01530) announces that phase III clinical study of recombinant human thrombopoietin injection (®) for ITP indications in children has reached the preset main end point.

Junshi Bio (01877): notice of acceptance of drug clinical trial application obtained by JS203 for injection

Junshi Bio (01877): notice of approval of supplementary drug application for "triplet monoclonal antibody injection"

AAC Technologies Holdings Inc. (02018) affiliated Chengrui Optics introduced new strategic investors such as Changzhou Xinbei and Changzhou Changgaoxin.

Keji Pharmaceutical-B (02171): CT041 is well tolerated and its safety risk can be controlled.

Hansoh Pharmaceutical Group (03692): the application for listing license for new indications of "Pemosapeptide injection" was accepted by the State Drug Administration.

And Platinum Medicine-B (02142) will announce the research progress of HBM4003 monotherapy and combination therapy with anti-PD-1 antibody at the annual meeting of ASCO 2022.

Geely Automobile (00175) subsidiary plans to increase its holdings of 45.375 million shares of Renault Korea Motors by about 1.376 billion yuan.

China Resources Pharmaceutical (03320) has signed a strategic cooperation agreement with Henan Real Biotechnology.

China Electric Power (02380) proposes to adopt new equity incentive scheme

Beijing Energy International (00686) subsidiary signs rooftop photovoltaic project agreement

Chizi City Science and Technology (09911) won Chairman Liu Chunhe to increase its stake by 100000 shares.

Weichai Power (02338): the State Administration of Market Supervision and Administration agreed to withdraw the application for the concentration of operators in the acquisition of Weichai Leiwo.

Financial report data

Geely Automobile (00175) sold about 50500 pure electric vehicles in the first four months, an increase of 6.87 times compared with the same period last year.

FIT HON TENG (06088) first quarter continuing operating net profit of US $30.592 million increased 1.69 times compared with the same period last year.

Yuexiu Real Estate (00123) April contract sales of 12.544 billion yuan increased by about 61% compared with the same period last year.

China Longyuan Power Group Corporation (00916) completed 6.601 million megawatt hours in April, an increase of 19.53% over the same period last year.

The mobile card (09923) released the business situation in the first quarter, and the total payment transaction volume was about 544.6 billion yuan, an increase of 18.2% over the same period last year.

Xintian Green Energy (00956) completed 1.436 million megawatts in April with a year-on-year increase of 9.9%.

Cosco Group (03377) agreed sales of 6.83 billion yuan in April.

The contract sales of Shangkun Real Estate (06900) in the first four months are about 3.42 billion yuan.

Longguang Group (03380) has contract sales of about 3.2 billion yuan in April.

Yuzhou Group (01628) April contract sales of 2.612 billion yuan

Cofco Jiakang (01610) the number of pigs produced in April decreased by 7.54% from the previous month to 368000.

Li Auto Inc.-W (02015) released a total income of 9.562 billion yuan in the first quarter, a decrease of 10.0% compared with the previous quarter.

Qiu Ti Technology (01478) A total of 33.624 million camera modules were sold in April, down 21.5% from a year earlier.

Hopson Development (00754) total contract sales of 10.583 billion yuan in the first four months fell 29.1% from the same period last year.

Contract sales of China overseas Hongyang Group (00081) in the first four months were 12.068 billion yuan, down 44.3% year on year.

Metro Development (01030) April contract sales of 9.029 billion yuan decreased by 56.53% compared with the same period last year

Longfor Group (00960) accumulated contract sales of 31.43 billion yuan in the first 4 months.

Repurchase cancellation

Standard Chartered PLC (02888) spent about 10.64 million pounds to buy back about 1.888 million shares

HSBC Holdings PLC (00005) spent about 8.0841 million pounds to buy back 1.6 million shares on May 6th.

Ping An Insurance (02318) spent 171 million yuan to buy back 3.858 million A shares on May 10.

AIA Group Limited (01299) spent about HK $163 million to buy back 2.2222 million shares on May 10.

JD Health (06618) buys back 2.25 million shares on May 10th

Skyworth Group (00751) spent HK $43.148 million to buy back 9.642 million shares on May 10.

GF Securities Co., LTD. (01776) buyback 2 million shares with 30.5186 million yuan on May 10th

Zhongsheng Group (00881) spent HK $30.235 million to buy back 617000 shares on May 10.

China Vanke (02202) spent 21.6656 million yuan to buy back 1.1979 million shares on May 10.

Pop Mart International (09992) invested about HK $9.9959 million to buy back 344800 shares on May 10.

CK Asset (01113) spent HK $8.7105 million to buy back 170000 shares on May 10.

Lizhu Pharmaceutical (01513) cancels 3.4044 million shares and has repurchased H shares

Sinotrans (00598) plans to spend no more than 299 million yuan to buy back A shares.

Sino Biopharmaceutical (01177): the trustee purchased 10 million shares under the share incentive scheme

Delisting and delisting

Razer (01337): the privatization proposal was approved by the Grand Court to delist on May 13.

Additional placement

China China Eastern Airlines Corp Ltd (00670) intends to issue no more than 5.662 billion A shares in a private offering.

Change of equity

China Resources Pharmaceutical (03320): China Resources Sanjiu (000999.SZ) plans to increase its stake in Kunming Pharmaceutical Group (600422.SH) by 2.902 billion yuan to about 212 million shares.

Xinhua Wenxuan (00811): Sichuan Xinhua Publishing and Distribution Group has completed the implementation of the plan to increase its holdings by 53.08 million H shares.

Stock option

BeiGene, Ltd. (06160) granted 6217 American depositary shares share options

AsiaInfo Technology (01675) granted 3.6483 million share options

Bond bill

Poly Real Estate Group (00119) issues 1.046 billion yuan of commercial real estate backed securities

Personnel change

Asian cement (China) (00743): Wu Zhongzhong resigns as CEO

China ship Leasing (03877): Chen Hui resigned as Deputy General Manager of the Company

Edit / new

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment